MTOR and cancer: Furthermore, Chen et al. indicated that colon CSCs (CD133/CD44/CD24) possess high PI3K/Akt/mTOR activities that can be inhibited by the dual inhibitor BEZ235 to achieve an effective reversal of insulin-regulated colon CSC stemness resulting in the secession of cancer cell proliferation and survival.